{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:36Z","timestamp":1787028636619,"version":"build-2736575974"},"reference-count":141,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease with a heterogeneous presentation, symptomatology, disease progression, and response to therapy. The current risk stratification assessment, aimed at identifying patients with a higher risk of disease progression, encompasses an in-depth analysis of demographic data, clinical and laboratory findings, antibody profiles, and the evaluation of liver fibrosis using both invasive and noninvasive techniques. Treatment response scores after one year of therapy remain to date a major factor influencing the prognosis of PBC patients. While the initial therapeutic approach with ursodeoxycholic acid (UDCA) is universally applied, new second-line treatment options have recently emerged, with many others under investigation. Consequently, the prevailing one-size-fits-all approach is poised to be supplanted by tailored strategies, ensuring high-risk patients receive the most appropriate treatment regimen from diagnosis. This will require the development of a risk prediction model to assess, at the time of diagnosis, the course, outcome, and response to first and additional treatments of PBC patients. This manuscript provides a comprehensive overview of the current and emerging tools used for risk stratification in PBC and speculates on how these developments might shape the disease landscape in the near future.<\/jats:p>","DOI":"10.3390\/jcm12175713","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T09:12:22Z","timestamp":1693559542000},"page":"5713","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk Stratification in Primary Biliary Cholangitis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-9327","authenticated-orcid":false,"given":"Francesco","family":"Martini","sequence":"first","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-1366","authenticated-orcid":false,"given":"Daniele","family":"Balducci","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Mancinelli","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Buzzanca","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fracchia","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantino","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Benedetti","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marzioni","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maroni","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary Biliary Cholangitis: Pathogenesis and Therapeutic Opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary Biliary Cirrhosis: An Orchestrated Immune Response against Epithelial Cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale Characterization Study of Patients with Antimitochondrial Antibodies but Nonestablished Primary Biliary Cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The Diagnosis and Management of Patients with Primary Biliary Cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in Liver Transplantation for Primary Biliary Cholangitis in Europe over the Past Three Decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00535-009-0090-2","article-title":"Mortality Rate of Patients with Asymptomatic Primary Biliary Cirrhosis Diagnosed at Age 55 Years or Older Is Similar to That of the General Population","volume":"44","author":"Kubota","year":"2009","journal-title":"J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2018.12.028","article-title":"Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-Free Survival in Patients With Primary Biliary Cholangitis","volume":"17","author":"Cheung","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00038-020-01391-6","article-title":"Epidemiology and Clinical Course of Primary Biliary Cholangitis in Eastern Slovakia","volume":"65","author":"Drazilova","year":"2020","journal-title":"Int. J. Public Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jgh.14521","article-title":"Prognosis of 732 Ursodeoxycholic Acid-treated Patients with Primary Biliary Cholangitis: A Single Center Follow-up Study from China","volume":"34","author":"Chen","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/00365521.2019.1683226","article-title":"Sex Differences in Clinical Presentation and Prognosis in Patients with Primary Biliary Cholangitis","volume":"54","author":"Abdulkarim","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-Based Epidemiology of Primary Biliary Cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_16","first-page":"268","article-title":"Increased Cancer Risk in a Large Population-Based Cohort of Patients with Primary Biliary Cirrhosis: Follow-up for up to 36 Years","volume":"8","author":"Boonstra","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MCG.0b013e3181f18c4e","article-title":"Varices in Early Histological Stage Primary Biliary Cirrhosis","volume":"45","author":"Ali","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"47890","DOI":"10.1038\/s41598-019-47890-2","article-title":"Incidence, Prevalence, and Outcome of Primary Biliary Cholangitis in a Nationwide Swedish Population-Based Cohort","volume":"9","author":"Marschall","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","article-title":"Geoepidemiology, Clinical Manifestations and Outcome of Primary Biliary Cholangitis in Greece","volume":"42","author":"Gatselis","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCG.0000000000001120","article-title":"Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis","volume":"53","author":"Younossi","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.31776","article-title":"Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis","volume":"74","author":"John","year":"2021","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10620-020-06402-3","article-title":"Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA","volume":"66","author":"Adejumo","year":"2021","journal-title":"Dig. Dis. Sci"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","article-title":"Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis","volume":"66","author":"Natarajan","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of Hepatocellular Carcinoma Risk in Primary Biliary Cirrhosis: A Multicentre International Study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","article-title":"Incidence of and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis: National Data from Japan","volume":"57","author":"Harada","year":"2013","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s00535-013-0903-1","article-title":"Biochemical Response to Ursodeoxycholic Acid Predicts Survival in a North American Cohort of Primary Biliary Cirrhosis Patients","volume":"49","author":"Lammert","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e23501","DOI":"10.1002\/jcla.23501","article-title":"A Nomogram Based on Pretreatment Clinical Parameters for the Prediction of Inadequate Biochemical Response in Primary Biliary Cholangitis","volume":"34","author":"Tian","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.ejim.2012.09.004","article-title":"Primary Biliary Cirrhosis in Southern Israel: A 20year Follow up Study","volume":"23","author":"Delgado","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/MEG.0000000000001186","article-title":"Influence Factors and a Predictive Scoring Model for Measuring the Biochemical Response of Primary Biliary Cholangitis to Ursodeoxycholic Acid Treatment","volume":"30","author":"Chen","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3325\/cmj.2019.60.494","article-title":"Epidemiological and Clinical Features of Primary Biliary Cholangitis in Two Croatian Regions: A Retrospective Study","volume":"60","author":"Madir","year":"2019","journal-title":"Croat. Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ueg2.12095","article-title":"Predictors for Incomplete Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis. Data from a National Registry of Liver Disease","volume":"9","author":"Liberal","year":"2021","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Invernizzi, F., Cilla, M., Trapani, S., Guarino, M., Cossiga, V., Gambato, M., Morelli, M.C., Morisco, F., Burra, P., and Floreani, A. (2022). Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060925"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100248","DOI":"10.1016\/j.jhepr.2021.100248","article-title":"Real-World Experience with Obeticholic Acid in Patients with Primary Biliary Cholangitis","volume":"3","author":"Malinverno","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of Primary Biliary Cirrhosis on Perceived Quality of Life: The UK-PBC National Study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.cgh.2018.12.007","article-title":"Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom","volume":"17","author":"Hegade","year":"2019","journal-title":"Clin. Gastroenterol. And. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.20276","article-title":"Quality of Life in Patients with Primary Biliary Cirrhosis","volume":"40","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.12560","article-title":"Fatigue and Pruritus at Onset Identify a More Aggressive Subset of Primary Biliary Cirrhosis","volume":"35","author":"Quarneti","year":"2015","journal-title":"Liver. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2010.05.026","article-title":"The Independent Effects of Fatigue and UDCA Therapy on Mortality in Primary Biliary Cirrhosis: Results of a 9year Follow-Up","volume":"53","author":"Jones","year":"2010","journal-title":"J. Hepatol"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic Primary Biliary Cirrhosis: Clinical Features, Prognosis, and Symptom Progression in a Large Population Based Cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(90)90968-7","article-title":"Symptom Development and Prognosis in Primary Biliary Cirrhosis: A Study in Two Centers","volume":"99","author":"Mitchison","year":"1990","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary Biliary Cirrhosis: Survival of a Large Cohort of Symptomatic and Asymptomatic Patients Followed for 24 Years","volume":"20","author":"Mahl","year":"1994","journal-title":"J. Hepatol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2018.11.008","article-title":"Epidemiology of Primary Biliary Cholangitis in Italy: Evidence from a Real-World Database","volume":"51","author":"Marzioni","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic Autoimmune Diseases in Primary Biliary Cholangitis: Prevalence and Significance for Clinical Presentation and Disease Outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J. Gastroenterol. Hepatol"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap Syndromes: The International Autoimmune Hepatitis Group (IAIHG) Position Statement on a Controversial Issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap Syndrome: Clinical Features and Response to Therapy","volume":"28","author":"Wendum","year":"1998","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap Syndromes","volume":"33","year":"2015","journal-title":"Dig. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune Hepatitis\u2013PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long Term Outcome and Response to Therapy of Primary Biliary Cirrhosis\u2014Autoimmune Hepatitis Overlap Syndrome","volume":"44","author":"Wendum","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in Non-Cirrhotic Primary Biliary Cirrhosis: The Premature Ductopenic Variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.dld.2016.05.023","article-title":"Toward Precision Medicine in Primary Biliary Cholangitis","volume":"48","author":"Carbone","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-979469","article-title":"Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases","volume":"27","author":"Invernizzi","year":"2007","journal-title":"Semin. Liver. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cld.2015.08.003","article-title":"Making Sense of Autoantibodies in Cholestatic Liver Diseases","volume":"20","author":"Marzorati","year":"2016","journal-title":"Clin. Liver. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2002.05620.x","article-title":"Antimitochondrial Antibody Profiles: Are They Valid Prognostic Indicators in Primary Biliary Cirrhosis?","volume":"97","author":"Joshi","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3748\/wjg.v20.i10.2606","article-title":"Autoantibodies in Primary Biliary Cirrhosis: Recent Progress in Research on the Pathogenetic and Clinical Significance","volume":"20","author":"Yamagiwa","year":"2014","journal-title":"World. J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","article-title":"Long-Term Outcomes in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis","volume":"51","author":"Juliusson","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2009). EASL Clinical Practice Guidelines: Management of Cholestatic Liver Diseases. J. Hepatol., 51, 237\u2013267.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver Autoimmune Serology: A Consensus Statement from the Committee for Autoimmune Serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cld.2008.02.003","article-title":"Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis","volume":"12","author":"Hirschfield","year":"2008","journal-title":"Clin. Liver. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1751-2980.12787","article-title":"Precision Medicine in Primary Biliary Cholangitis","volume":"20","author":"Ronca","year":"2019","journal-title":"J. Dig. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of Initial Autoantibody Profile and Clinical Outcome in Primary Biliary Cirrhosis","volume":"43","author":"Penner","year":"2006","journal-title":"Hepatology"},{"key":"ref_64","first-page":"1","article-title":"Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis","volume":"2019","author":"Huang","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/liv.14688","article-title":"Antibodies to Gp210 and Understanding Risk in Patients with Primary Biliary Cholangitis","volume":"41","author":"Haldar","year":"2021","journal-title":"Liver. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The Risk Predictive Values of UK-PBC and GLOBE Scoring System in Chinese Patients with Primary Biliary Cholangitis: The Additional Effect of Anti-Gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"98076","DOI":"10.3389\/fimmu.2022.1098076","article-title":"Using Two-Step Cluster Analysis to Classify Inpatients with Primary Biliary Cholangitis Based on Autoantibodies: A Real-World Retrospective Study of 537 Patients in China","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical Significance of the Fluctuation of Primary Biliary Cirrhosis-Related Autoantibodies during the Course of the Disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.14309\/ajg.0000000000000690","article-title":"Novel Anti\u2013Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis","volume":"115","author":"Reig","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","article-title":"The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis","volume":"144","author":"Tana","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and Clinical Significance of Anti-Centromere Antibodies in Primary Biliary Cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-Gp210 and Anti-Centromere Antibodies Are Different Risk Factors for the Progression of Primary Biliary Cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The Value of Antinuclear Antibodies in Primary Biliary Cirrhosis","volume":"8","author":"Gao","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-Kelch-like 12 and Anti-Hexokinase 1: Novel Autoantibodies in Primary Biliary Cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","article-title":"Role of Autoantibodies in the Clinical Management of Primary Biliary Cholangitis","volume":"29","author":"Rigopoulou","year":"2023","journal-title":"World. J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.14309\/ajg.0000000000000765","article-title":"Role of Antinuclear Antibodies in Primary Biliary Cholangitis","volume":"115","author":"Levy","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Bauer, A., Habior, A., and Gawel, D. (2022). Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040801"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/apt.15533","article-title":"Fibrosis Stage Is an Independent Predictor of Outcome in Primary Biliary Cholangitis despite Biochemical Treatment Response","volume":"50","author":"Hirschfield","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_79","first-page":"387","article-title":"Primary Biliary Cirrhosis. Chronic non-suppurative destructive cholangitis","volume":"46","author":"Rubin","year":"1965","journal-title":"Am. J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2152\/jmi.64.7","article-title":"Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms","volume":"64","author":"Tsuneyama","year":"2017","journal-title":"J. Med. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary Biliary Cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of Chronic Nonsuppurative Destructive Cholangitis (Syndrome of Primary Biliary Cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch. A. Pathol. Anat. Histol."},{"key":"ref_83","first-page":"1257","article-title":"Primary Biliary Cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc. R. Soc. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological Study of Primary Biliary Cirrhosis and the Effect of Ursodeoxycholic Acid Treatment on Histology Progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MCG.0b013e31827234e4","article-title":"Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis","volume":"47","author":"Harada","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis in Comparison with Classical Systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a New Histological Staging and Grading System for Primary Biliary Cirrhosis to Liver Biopsy Specimens: Interobserver Agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/liv.12620","article-title":"Primary Biliary Cirrhosis: Proposal for a New Simple Histological Scoring System","volume":"35","author":"Wendum","year":"2015","journal-title":"Liver. Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1111\/hepr.12746","article-title":"Liver Fibrosis Progression Predicts Survival in Patients with Primary Biliary Cirrhosis","volume":"47","author":"Namisaki","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver Biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/hepr.13355","article-title":"Identification of Clinical Risk Factors for Histological Progression of Primary Biliary Cholangitis","volume":"49","author":"Fujinaga","year":"2019","journal-title":"Hepatol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Sekiguchi, T., Umemura, T., Fujimori, N., Shibata, S., Ichikawa, Y., Kimura, T., Joshita, S., Komatsu, M., Matsumoto, A., and Tanaka, E. (2015). Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131658"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising Risk Stratification in Primary Biliary Cirrhosis: AST\/Platelet Ratio Index Predicts Outcome Independent of Ursodeoxycholic Acid Response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e27403","DOI":"10.1097\/MD.0000000000027403","article-title":"Enhanced Liver Fibrosis Score as a Surrogate of Liver-Related Complications and Mortality in Primary Biliary Cholangitis","volume":"100","author":"Fujinaga","year":"2021","journal-title":"Medicine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","article-title":"Serum Wisteria Floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis","volume":"110","author":"Umemura","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hepr.12595","article-title":"Impact of Serum Wisteria Floribunda Agglutinin Positive Mac-2-Binding Protein and Serum Interferon-\u03b3-Inducible Protein-10 in Primary Biliary Cirrhosis","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCG.0000000000001433","article-title":"Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis","volume":"55","author":"Osman","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient Elastography: A New Noninvasive Method for Assessment of Hepatic Fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound. Med. Biol."},{"key":"ref_99","first-page":"828","article-title":"Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations","volume":"5","author":"Foucher","year":"2010","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and Diagnostic Performance of the FibroScan XL Probe for Liver Stiffness Measurement in Overweight and Obese Patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MCG.0b013e3181b4af1f","article-title":"A Meta-Analysis of Transient Elastography for the Detection of Hepatic Fibrosis","volume":"44","author":"Stebbing","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-Invasive Evaluation of Liver Fibrosis Using Transient Elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive Elastography-Based Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/hep.31810","article-title":"Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Na\u00efve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach","volume":"74","author":"Cristoferi","year":"2021","journal-title":"Hepatology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","article-title":"Liver Stiffness Measurement by Vibration-Controlled Transient Elastography Improves Outcome Prediction in Primary Biliary Cholangitis","volume":"77","author":"Corpechot","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ultrasmedbio.2008.08.018","article-title":"Quantitative Viscoelasticity Mapping of Human Liver Using Supersonic Shear Imaging: Preliminary In Vivo Feasability Study","volume":"35","author":"Muller","year":"2009","journal-title":"Ultrasound Med. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.dld.2020.02.002","article-title":"Assessment of Biopsy Proven Liver Fibrosis by Two-Dimensional Shear Wave Elastography in Patients with Primary Biliary Cholangitis","volume":"52","author":"Yan","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.21037\/qims-21-657","article-title":"Shear Wave Elastography and Shear Wave Dispersion Imaging in Primary Biliary Cholangitis\u2014A Pilot Study","volume":"12","author":"Schulz","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0301-5629(01)00499-9","article-title":"Acoustic Radiation Force Impulse Imaging: In Vivo Demonstration of Clinical Feasibility","volume":"28","author":"Nightingale","year":"2002","journal-title":"Ultrasound Med. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5604\/01.3001.0012.7858","article-title":"Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases","volume":"18","author":"Goertz","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jmri.23731","article-title":"Magnetic Resonance Elastography of Liver: Technique, Analysis, and Clinical Applications","volume":"37","author":"Venkatesh","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mri.2014.10.003","article-title":"Comparison of the Diagnostic Accuracies of Magnetic Resonance Elastography and Transient Elastography for Hepatic Fibrosis","volume":"33","author":"Ichikawa","year":"2015","journal-title":"Magn. Reson. Imaging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-Analysis of Individual Participant Data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis in Primary Biliary Cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cgh.2020.08.006","article-title":"Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients with Primary Biliary Cholangitis","volume":"19","author":"Gerussi","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary Biliary Cholangitis: Epidemiology, Prognosis, and Treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in Primary Biliary Cirrhosis: Model for Decision Making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpg.2018.06.006","article-title":"Risk Stratification and Prognostic Modelling in Primary Biliary Cholangitis","volume":"34\u201335","author":"Goet","year":"2018","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase","volume":"115","author":"Harms","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.26322","article-title":"Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study","volume":"58","author":"Zhang","year":"2013","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.15592","article-title":"Optimizing Therapy in Primary Biliary Cholangitis: Alkaline Phosphatase at Six Months Identifies One-year Non-responders and Predicts Survival","volume":"43","author":"Ioannou","year":"2023","journal-title":"Liver Int."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00535-009-0051-9","article-title":"Early Biochemical Response to Ursodeoxycholic Acid Predicts Symptom Development in Patients with Asymptomatic Primary Biliary Cirrhosis","volume":"44","author":"Azemoto","year":"2009","journal-title":"J. Gastroenterol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early Primary Biliary Cirrhosis: Biochemical Response to Treatment and Prediction of Long-Term Outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-term Prediction of End-stage Liver Disease in Primary Biliary Cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep4.1180","article-title":"Clinical Application of the GLOBE and United Kingdom-primary Biliary Cholangitis Risk Scores in a Trial Cohort of Patients with Primary Biliary Cholangitis","volume":"2","author":"Carbone","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","article-title":"Pretreatment Prediction of Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis: Development and Validation of the UDCA Response Score","volume":"3","author":"Carbone","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/liv.14534","article-title":"A Validation Study of the Ursodeoxycholic Acid Response Score in Japanese Patients with Primary Biliary Cholangitis","volume":"40","author":"Yagi","year":"2020","journal-title":"Liver Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New Treatment Paradigms in Primary Biliary Cholangitis","volume":"21","author":"Levy","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaut.2018.10.024","article-title":"Prognostic Models in Primary Biliary Cholangitis","volume":"95","author":"Cristoferi","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/liv.12680","article-title":"Serum Metabolic Signatures of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis","volume":"35","author":"Bell","year":"2015","journal-title":"Liver Int."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.2144\/fsoa-2019-0124","article-title":"Metabolomic Biomarkers Are Associated with Mortality in Patients with Cirrhosis Caused by Primary Biliary Cholangitis or Primary Sclerosing Cholangitis","volume":"6","author":"Mindikoglu","year":"2020","journal-title":"Future Sci. OA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41598-017-00944-9","article-title":"Serum Metabolomics Analysis Reveals a Distinct Metabolic Profile of Patients with Primary Biliary Cholangitis","volume":"7","author":"Hao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep4.1871","article-title":"High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases","volume":"6","author":"Walker","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e715852","DOI":"10.3389\/fphys.2021.715852","article-title":"The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/femsle\/fnab038","article-title":"Short-Chain Fatty Acid and Fecal Microbiota Profiles Are Linked to Fibrosis in Primary Biliary Cholangitis","volume":"368","author":"Lammert","year":"2021","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/liv.15141","article-title":"Machine Learning in Primary Biliary Cholangitis: A Novel Approach for Risk Stratification","volume":"42","author":"Gerussi","year":"2022","journal-title":"Liver Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jceh.2022.06.009","article-title":"Artificial Intelligence in Hepatology- Ready for the Primetime","volume":"13","author":"Kalapala","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e966329","DOI":"10.3389\/fimmu.2022.966329","article-title":"Artificial Intelligence for Precision Medicine in Autoimmune Liver Disease","volume":"13","author":"Gerussi","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5713\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:44:49Z","timestamp":1760129089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":141,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12175713"],"URL":"https:\/\/doi.org\/10.3390\/jcm12175713","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}